TrademarkDir
PERSONALIZED BREAST CANCER
DEAD

Serial Number

85538950

Owner

GREEN HILL HEALTHCARE COMMUNICATIONS, LLC

Attorney

Brian L. Petrequin

Filing Date

Feb 9, 2012

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

PERSONALIZED BREAST CANCER Trademark

Serial Number: 85538950

PERSONALIZED BREAST CANCER is a trademark filed by GREEN HILL HEALTHCARE COMMUNICATIONS, LLC on February 9, 2012. The trademark is classified under Class 41 (Education & Entertainment). The application is currently no longer active.

Owner Contact Info

GREEN HILL HEALTHCARE COMMUNICATIONS, LLC (86 trademarks)

Cranbury, NJ 08512

Entity Type: 16

Trademark Details

Filing Date

February 9, 2012

Registration Date

Not Registered

Published for Opposition

January 1, 2013

Goods & Services

Online educational services, namely, providing continuing professional education courses and examinations in the fields oncology and cancer via a global computer information network; providing online information about continuing education in the fields of hematology, oncology and cancer

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Aug 8, 2016 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 8, 2016 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 3, 2016 EXRA
SOU EXTENSION 5 GRANTED
Feb 2, 2016 EX5G
SOU EXTENSION 5 FILED
Dec 31, 2015 EXT5
SOU TEAS EXTENSION RECEIVED
Dec 31, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 9, 2015 EXRA
SOU EXTENSION 4 GRANTED
Jul 8, 2015 EX4G
SOU EXTENSION 4 FILED
Jun 29, 2015 EXT4
SOU TEAS EXTENSION RECEIVED
Jun 29, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 29, 2015 EXRA
SOU EXTENSION 3 GRANTED
Jan 28, 2015 EX3G
SOU EXTENSION 3 FILED
Jan 2, 2015 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 2, 2015 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 9, 2014 EXRA
SOU EXTENSION 2 GRANTED
Jul 8, 2014 EX2G
NOTICE OF REVIVAL - E-MAILED
Jul 3, 2014 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jul 3, 2014 TPEX
PETITION TO REVIVE-GRANTED
Jul 3, 2014 PETG
TEAS PETITION TO REVIVE RECEIVED
Jul 3, 2014 PROA
SOU EXTENSION 2 FILED
Jul 2, 2014 EXT2
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 12, 2014 EXRA
SOU EXTENSION 1 GRANTED
Feb 11, 2014 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 31, 2014 AITU
SOU EXTENSION 1 FILED
Dec 20, 2013 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 20, 2013 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 2, 2013 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
May 17, 2013 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jan 28, 2013 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 1, 2013 NPUB
PUBLISHED FOR OPPOSITION
Jan 1, 2013 PUBO
LETTER OF PROTEST EVIDENCE FORWARDED
Dec 14, 2012 LOPT
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 12, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 24, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 20, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 20, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 20, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 20, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 7, 2012 GNRN
NON-FINAL ACTION E-MAILED
Nov 7, 2012 GNRT
NON-FINAL ACTION WRITTEN
Nov 7, 2012 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 26, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 25, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 25, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 25, 2012 GNRN
NON-FINAL ACTION E-MAILED
Apr 25, 2012 GNRT
NON-FINAL ACTION WRITTEN
Apr 25, 2012 CNRT
ASSIGNED TO EXAMINER
Apr 25, 2012 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 28, 2012 AMPX
ASSIGNED TO LIE
Mar 21, 2012 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 6, 2012 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 15, 2012 NWOS
NEW APPLICATION ENTERED
Feb 13, 2012 NWAP

Related Trademarks

More from this Owner

IMMUNO-ONCOLOGY NEWS

IMMUNO-ONCOLOGY NEWS

IMMUNOTHERAPY IN ONCOLOGY

IMMUNOTHERAPY IN ONCOLOGY

IMMUNOLOGY NEWS

IMMUNOLOGY NEWS

IMMUNOLOGY NEWS

IMMUNOLOGY NEWS

IMMUNOTHERAPY IN ONCOLOGY

IMMUNOTHERAPY IN ONCOLOGY

IMMUNO-ONCOLOGY NEWS

IMMUNO-ONCOLOGY NEWS